Literature DB >> 18223240

Are triple-negative and basal-like breast cancer synonymous?

Emad Rakha, Ian Ellis, Jorge Reis-Filho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18223240     DOI： 10.1158/1078-0432.CCR-07-1943

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  13 in total

1.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.

Authors:  Tor W Jensen; Tania Ray; Jinhua Wang; Xiaodong Li; Wesley Y Naritoku; Bingchen Han; Frank Bellafiore; Sanjay P Bagaria; Annie Qu; Xiaojiang Cui; Clive R Taylor; Partha S Ray
Journal:  J Natl Cancer Inst       Date:  2015-06-03       Impact factor: 13.506

3.  Transgelin: a potentially useful diagnostic marker differentially expressed in triple-negative and non-triple-negative breast cancers.

Authors:  Deepthi Rao; Bruce F Kimler; Warren B Nothnick; Marilyn K Davis; Fang Fan; Ossama Tawfik
Journal:  Hum Pathol       Date:  2015-03-10       Impact factor: 3.466

4.  Molecular classification predicts survival for breast cancer patients in Vietnam: a single institutional retrospective analysis.

Authors:  Chu Van Nguyen; Quang Tien Nguyen; Ha Thi Ngoc Vu; Khoa Hong Pham; Huyen Thi Phung
Journal:  Int J Clin Exp Pathol       Date:  2021-03-01

5.  Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival.

Authors:  Yoon-La Choi; Ensel Oh; Sarah Park; Yeonju Kim; Yeon-Hee Park; Kyoung Song; Eun Yoon Cho; Yun-Chul Hong; Jong Sun Choi; Jeong Eon Lee; Jung Han Kim; Seok Jin Nam; Young-Hyuck Im; Jung-Hyun Yang; Young Kee Shin
Journal:  BMC Cancer       Date:  2010-09-23       Impact factor: 4.430

6.  May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis.

Authors:  Hai Wang; Bing Guan; Qunli Shi; Henhui Ma; Hangbo Zhou; Xuan Wang; Xiaojun Zhou
Journal:  Med Oncol       Date:  2009-12-30       Impact factor: 3.064

7.  Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?

Authors:  André Albergaria; Sara Ricardo; Fernanda Milanezi; Vítor Carneiro; Isabel Amendoeira; Daniella Vieira; Jorge Cameselle-Teijeiro; Fernando Schmitt
Journal:  BMC Cancer       Date:  2011-07-15       Impact factor: 4.430

8.  Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.

Authors:  Giuseppina Rosaria Rita Ricciardi; Barbara Adamo; Antonio Ieni; Luana Licata; Roberta Cardia; Giuseppa Ferraro; Tindara Franchina; Giovanni Tuccari; Vincenzo Adamo
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

9.  The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.

Authors:  Danielle Bogan; Lucio Meile; Ahmed El Bastawisy; Hend F Yousef; Abdel-Rahman N Zekri; Abeer A Bahnassy; Wael M ElShamy
Journal:  BMC Cancer       Date:  2017-05-12       Impact factor: 4.430

10.  ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.

Authors:  Christoforos Thomas; Gayani Rajapaksa; Fotis Nikolos; Ruixin Hao; Anne Katchy; Catherine W McCollum; Maria Bondesson; Phil Quinlan; Alastair Thompson; Savitri Krishnamurthy; Francisco J Esteva; Jan-Åke Gustafsson
Journal:  Breast Cancer Res       Date:  2012-11-16       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.